ArticleCureus2025
Systemic Lupus Erythematosus Complicated by Spontaneous Splenic Rupture.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spontaneous splenic rupture (SSR) is an uncommon but life-threatening surgical emergency. When it occurs as a complication of systemic lupus erythematosus (SLE), the diagnostic and therapeutic strategy becomes particularly complex. Published literature on SSR in the setting of SLE is sparse, and there is no clear consensus on the optimal management of such a surgical catastrophe. What is the optimal treatment strategy for patients with SSR complicated by SLE? This paper addresses these questions by providing an in-depth analysis of a representative case of SLE complicated by SSR that we successfully diagnosed and treated. Our case study details the patient's entire clinical course, from the initial presentation with non-specific abdominal pain, through confirmation via imaging diagnostics, to the final recovery achieved through a personalized treatment plan developed by a multidisciplinary team (MDT). A key finding of our research is the emphasis that, for patients with known autoimmune diseases such as SLE, the acute onset of abdominal pain, hemodynamic instability, or any signs of intra-abdominal bleeding should prompt clinicians to maintain a high index of suspicion and include SSR in the differential diagnosis. Rapid identification, multidisciplinary collaboration (involving close coordination among rheumatology, critical care, surgery, and radiology), and individualized treatment decisions based on the patient's specific condition are the cornerstones of successfully managing this severe complication and improving patient outcomes. We believe the significance of our findings lies in their potential to greatly enhance clinicians' understanding of this rare yet fatal complication of SLE. The detailed diagnostic and therapeutic pathway and the decision-making rationale provided in this report can serve as a valuable reference guide for colleagues worldwide when faced with similar challenging cases, potentially saving more patients' lives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.